India eyes Russia, Brazil, Netherlands for pharma export growth as US tariffs concerns linger

India is strategically planning to boost its pharmaceutical exports to Russia, the Netherlands, and Brazil, aiming to reduce reliance on the U.S. market due to tariff concerns. While the U.S. remains a crucial market, India seeks to diversify its export chain and increase market share in these growing regions.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/i1YXg7P
via IFTTT